XML 127 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Effect of Net Investment Hedges
The effects of the Company’s net investment hedges on OCI and the Consolidated Statement of Income are shown below:
 
Amount of Pretax (Gain) Loss Recognized in Other Comprehensive Income (1)
 
Amount of Pretax (Gain) Loss Recognized in Other (income) expense, net for Amounts Excluded from Effectiveness Testing
Years Ended December 31
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Net Investment Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
(10
)
 
$
(18
)
 
$

 
$
(31
)
 
$
(11
)
 
$

Euro-denominated notes
(75
)
 
(183
)
 
520

 

 

 

(1) No amounts were reclassified from AOCI into income related to the sale of a subsidiary.
Summary of Interest Rate Derivatives
At December 31, 2019, the Company was a party to 19 pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges of fixed-rate notes in which the notional amounts match the amount of the hedged fixed-rate notes as detailed in the table below.
 
2019
Debt Instrument
Par Value of Debt
 
Number of Interest Rate Swaps Held
 
Total Swap Notional Amount
1.85% notes due 2020
$
1,250

 
5

 
$
1,250

3.875% notes due 2021
1,150

 
5

 
1,150

2.40% notes due 2022
1,000

 
4

 
1,000

2.35% notes due 2022
1,250

 
5

 
1,250

Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position
The table below presents the location of amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges as of December 31:
 
Carrying Amount of Hedged Liabilities
 
Cumulative Amount of Fair Value Hedging Adjustment Increase (Decrease) Included in the Carrying Amount
 
2019
 
2018
 
2019
 
2018
Balance Sheet Line Item in which Hedged Item is Included
 
 
 
 
 
 
 
Loans payable and current portion of long-term debt
$
1,249

 
$

 
$
(1
)
 
$

Long-Term Debt
3,409

 
4,560

 
14

 
(82
)
Fair Value of Derivatives on a Gross Basis Segregated Between those Derivatives that are Designated as Hedging Instruments and those that are Not Designated as Hedging Instruments
Presented in the table below is the fair value of derivatives on a gross basis segregated between those derivatives that are designated as hedging instruments and those that are not designated as hedging instruments as of December 31:
 
 
 
2019
 
2018
 
 
 
Fair Value of
Derivative
 
U.S. Dollar
Notional
 
Fair Value of
Derivative
 
U.S. Dollar
Notional
 
Balance Sheet Caption
 
Asset
 
Liability
 
Asset
 
Liability
 
Derivatives Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swap contracts
Other Assets
 
$
15

 
$

 
$
3,400

 
$

 
$

 
$

Interest rate swap contracts
Accrued and other current liabilities
 

 
1

 
1,250

 

 

 

Interest rate swap contracts
Other Noncurrent Liabilities
 

 

 

 

 
81

 
4,650

Foreign exchange contracts
Other current assets
 
152

 

 
6,117

 
263

 

 
6,222

Foreign exchange contracts
Other Assets
 
55

 

 
2,160

 
75

 

 
2,655

Foreign exchange contracts
Accrued and other current liabilities
 

 
22

 
1,748

 

 
7

 
774

Foreign exchange contracts
Other Noncurrent Liabilities
 

 
1

 
53

 

 
1

 
89

 
 
 
$
222


$
24


$
14,728


$
338


$
89


$
14,390

Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Other current assets
 
$
66

 
$

 
$
7,245

 
$
116

 
$

 
$
5,430

Foreign exchange contracts
Accrued and other current liabilities
 

 
73

 
8,693

 

 
71

 
9,922

 
 
 
$
66

 
$
73

 
$
15,938

 
$
116

 
$
71

 
$
15,352

 
 
 
$
288

 
$
97

 
$
30,666

 
$
454

 
$
160

 
$
29,742


Information on Derivative Positions Subject to Master Netting Arrangements as if they were Presented on a Net Basis The following table provides information on the Company’s derivative positions subject to these master netting arrangements as if they were presented on a net basis, allowing for the right of offset by counterparty and cash collateral exchanged per the master agreements and related credit support annexes at December 31:
 
2019
 
2018
 
Asset
 
Liability
 
Asset
 
Liability
Gross amounts recognized in the consolidated balance sheet
$
288

 
$
97

 
$
454

 
$
160

Gross amounts subject to offset in master netting arrangements not offset in the consolidated balance sheet
(84
)
 
(84
)
 
(121
)
 
(121
)
Cash collateral received
(34
)
 

 
(107
)
 

Net amounts
$
170

 
$
13

 
$
226

 
$
39


Location and Pretax Gain or Loss Amounts for Derivatives
The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value or cash flow hedging relationships:
 
Sales
 
Other (income) expense, net (1)
 
Other comprehensive income (loss)
Years Ended December 31
2019
 
2018
 
2017
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Financial Statement Line Items in which Effects of Fair Value or Cash Flow Hedges are Recorded
$
46,840

 
$
42,294

 
$
40,122

 
$
139

 
(402
)
 
(500
)
 
$
(648
)
 
$
(361
)
 
$
316

(Gain) loss on fair value hedging relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swap contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hedged items

 

 

 
95

 
(27
)
 
(48
)
 

 

 

Derivatives designated as hedging instruments

 

 

 
(65
)
 
50

 
12

 

 

 

Impact of cash flow hedging relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gain (loss) recognized in OCI on derivatives

 

 

 

 

 

 
87

 
228

 
(562
)
(Decrease) increase in Sales as a result of AOCI reclassifications
255

 
(160
)
 
138

 

 

 

 
(255
)
 
160

 
(138
)
Interest rate contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gain recognized in Other (income) expense, net on derivatives

 

 

 
(4
)
 
(4
)
 
(3
)
 

 

 

Amount of loss recognized in OCI on derivatives

 

 

 

 

 

 
(6
)
 
(4
)
 
(3
)
(1) Interest expense is a component of Other (income) expense, net.
Income Statement Effects of Derivatives Not Designated as Hedging Instruments
The table below provides information regarding the income statement effects of derivatives not designated as hedging instruments:
 
 
 
Amount of Derivative Pretax (Gain) Loss Recognized in Income
Years Ended December 31
Income Statement Caption
 
2019
 
2018
 
2017
Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
Foreign exchange contracts (1)
Other (income) expense, net
 
$
174

 
$
(260
)
 
$
110

Foreign exchange contracts (2)
Sales
 
1

 
(8
)
 
(3
)
(1) These derivative contracts mitigate changes in the value of remeasured foreign currency denominated monetary assets and liabilities attributable to changes in foreign currency exchange rates.
(2) These derivative contracts serve as economic hedges of forecasted transactions.
Information on Investments in Debt and Equity Securities
Information on investments in debt and equity securities at December 31 is as follows:
 
 
2019
 
2018
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
  
Gains
 
Losses
 
Gains
 
Losses
 
Commercial paper
$
668

 
$

 
$

 
$
668

 
$

 
$

 
$

 
$

Corporate notes and bonds
608

 
13

 

 
621

 
4,985

 
3

 
(68
)
 
4,920

U.S. government and agency securities
266

 
3

 

 
269

 
895

 
2

 
(5
)
 
892

Asset-backed securities
226

 
1

 

 
227

 
1,285

 
1

 
(11
)
 
1,275

Foreign government bonds

 

 

 

 
167

 

 
(1
)
 
166

Mortgage-backed securities

 

 

 

 
8

 

 

 
8

Total debt securities
1,768


17




1,785


7,340


6


(85
)

7,261

Publicly traded equity securities (1)
 
 
 
 
 
 
838

 
 
 
 
 
 
 
456

Total debt and publicly traded equity securities








 
$
2,623










 
$
7,717


(1) Unrealized net gains recognized in Other (income) expense, net on equity securities still held at December 31, 2019 were $160 million during 2019. Unrealized net losses recognized in Other (income) expense, net on equity securities still held at December 31, 2018 were $35 million during 2018.
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets and liabilities measured at fair value on a recurring basis at December 31 are summarized below:
 
Fair Value Measurements Using
 
Fair Value Measurements Using
  
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
  
2019
 
2018
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial paper
$

 
$
668

 
$

 
$
668

 
$

 
$

 
$

 
$

Corporate notes and bonds

 
621

 

 
621

 

 
4,835

 

 
4,835

Asset-backed securities (1)

 
227

 

 
227

 

 
1,253

 

 
1,253

U.S. government and agency securities

 
209

 

 
209

 

 
731

 

 
731

Foreign government bonds

 

 

 

 

 
166

 

 
166

Publicly traded equity securities
518

 

 

 
518

 
147

 

 

 
147

 
518


1,725




2,243

 
147


6,985




7,132

Other assets (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agency securities
60

 

 

 
60

 
55

 
106

 

 
161

Corporate notes and bonds

 

 

 

 

 
85

 

 
85

Asset-backed securities (1)

 

 

 

 

 
22

 

 
22

Mortgage-backed securities

 

 

 

 

 
8

 

 
8

Publicly traded equity securities
320

 

 

 
320

 
309

 

 

 
309

 
380






380


364


221




585

Derivative assets (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Forward exchange contracts

 
169

 

 
169

 

 
241

 

 
241

Purchased currency options

 
104

 

 
104

 

 
213

 

 
213

Interest rate swaps

 
15

 

 
15

 

 

 

 

 


288




288




454




454

Total assets
$
898


$
2,013


$


$
2,911


$
511


$
7,660


$


$
8,171

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent consideration
$

 
$

 
$
767

 
$
767

 
$

 
$

 
$
788

 
$
788

Derivative liabilities (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Forward exchange contracts

 
95

 

 
95

 

 
74

 

 
74

Interest rate swaps

 
1

 

 
1

 

 
81

 

 
81

Written currency options

 
1

 

 
1

 

 
5

 

 
5

 


97




97




160




160

Total liabilities
$


$
97


$
767


$
864


$


$
160


$
788


$
948

(1) 
Primarily all of the asset-backed securities are highly-rated (Standard & Poor’s rating of AAA and Moody’s Investors Service rating of Aaa), secured primarily by auto loan, credit card and student loan receivables, with weighted-average lives of primarily 5 years or less.
(2) 
Investments included in other assets are restricted as to use, including for the payment of benefits under employee benefit plans.
(3) 
The fair value determination of derivatives includes the impact of the credit risk of counterparties to the derivatives and the Company’s own credit risk, the effects of which were not significant.
Summarized Information about the Changes in Liabilities for Contingent Consideration
Summarized information about the changes in liabilities for contingent consideration associated with business acquisitions is as follows:
 
2019
 
2018
Fair value January 1
$
788

 
$
935

Changes in estimated fair value (1)
64

 
89

Additions

 
8

Payments
(85
)
 
(244
)
Fair value December 31 (2)(3)
$
767

 
$
788


(1) Recorded in Cost of sales, Research and development expenses, and Other (income) expense, net. Includes cumulative translation adjustments.
(2) Balance at December 31, 2019 includes $114 million recorded as a current liability for amounts expected to be paid within the next 12 months.
(3) At December 31, 2019 and 2018, $625 million and $614 million, respectively, of the liabilities relate to the termination of the SPMSD joint venture in 2016. As part of the termination, Merck recorded a liability for contingent future royalty payments of 11.5% on net sales of all Merck products that were previously sold by the joint venture through December 31, 2024. The fair value of this liability is determined utilizing the estimated amount and timing of projected cash flows and a risk-adjusted discount rate of 8% is used to present value the cash flows.